Delivery Order SPE2DX22D0049-SPE2D824FA3GF

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $123K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $320,799.51, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order contract is for the supply of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment. Amerisourcebergen, a major pharmaceutical distributor, will deliver these critical care materials to support...
This federal contract award, valued at $44,334.15, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December 2025. The contract is for the supply of various pharmaceutical products and medical supplies to support...
This federal contract award, valued at $41,779.50, was issued by the U.S. Defense Department's Medical Supply Chain organization (also known as the Defense Logistics Agency (DLA) Troop Support Medical) to Amerisourcebergen Drug Corp, the corporate office division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award, valued at $129,639.19, was issued by the Medical Supply Chain division of the U.S. Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order type and has a firm fixed-price pricing structure. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of prescription medications, over-the-counter drugs, and medical supplies to support the DLA's mission to...
This federal contract award, valued at $138,321.11, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The purpose of this award is to provide a wide range of pharmaceutical products and medical supplies to support military treatment...
This federal contract award, valued at $174,380.99, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and is not operating under a set-aside designation. The contract...
This federal contract award, valued at $81,101.24, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award, with a ceiling value of $46,978.10, is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $44,479.96 firm-fixed-price delivery order contract is for the provision of pharmaceutical products and medical supplies to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of October 1, 2024. Amerisourcebergen, a major pharmaceutical distributor...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at up to $4,792.23, is a Delivery Order for pharmaceutical products and medical supplies, with a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distributor, will provide a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government agencies...
  • SPE2DX22D0049
    Indefinite Delivery Contract
  • SPE2DX22D0049-SPE2D824FA3GF
    Delivery Order

This federal contract award, valued at $123,094.49, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, will provide a range of pharmaceutical products and medical supplies to support military treatment facilities and federal healthcare programs. The contract does not have a set-aside designation and is scheduled for completion by August 6, 2024. Amerisourcebergen's extensive supply chain and distribution capabilities enable it to efficiently deliver a diverse array of critical care materials, specialty medications, and other essential medical commodities to federal agencies and healthcare providers as needed.

Generated 11/4/24, 11:52 AM